TY - JOUR
T1 - Longitudinal changes in patient-reported outcomes after artificial urinary sphincter implantation
AU - Yokoyama, Minato
AU - Masuda, Hitoshi
AU - Ito, Masaya
AU - Waseda, Yuma
AU - Moriyama, Shingo
AU - Toide, Masahiro
AU - Uchida, Yusuke
AU - Uehara, Sho
AU - Kijima, Toshiki
AU - Yoshida, Soichiro
AU - Ishioka, Junichiro
AU - Matsuoka, Yoh
AU - Saito, Kazutaka
AU - Fujii, Yasuhisa
N1 - Publisher Copyright:
© 2020 John Wiley & Sons Australia, Ltd
PY - 2020/9/1
Y1 - 2020/9/1
N2 - Objective: To evaluate the time course of lower urinary tract symptoms (LUTS) after artificial urinary sphincter (AUS) implantation based on individual longitudinal changes of patient-reported outcomes. Methods: This retrospective study included 66 male patients with severe urinary incontinence who were treated with primary AUS implantation between 2009 and 2019. International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) and International Prostate Symptom Score (IPSS) questionnaires were used to evaluate continence status and LUTS preoperatively, 1, 3, and 12 months after activation, and then annually. The annual changes in scores were calculated with a linear mixed model. Results: Of the 66 patients, 63 (95%) achieved complete or social continence (number of pads used ≤1/d) at 1 month after activation. Mean preoperative ICIQ-SF, IPSS, and IPSS-quality of life (QOL) score were 18.9, 14.9, and 5.4, respectively; the corresponding scores at 1 month after activation were 4.5, 9.0, and 1.7 (all P <.001), respectively. During the mean follow-up period of 36 months, the annual changes in the scores from 1 month after activation were 0.51 (P =.002), −0.30 (P =.184), and 0.19 (P <.001), respectively. As for individual IPSS items, while incomplete emptying, frequency, urgency, and weak stream improved significantly 1 month after activation, no significant changes from 1 month after activation were observed except for longitudinal deterioration of incomplete emptying score (0.08/y, P =.029). Conclusion: Continence status and QOL score markedly improved by AUS implantation immediately, but deteriorated over time. Improved LUTS were maintained without a worsening trend, however.
AB - Objective: To evaluate the time course of lower urinary tract symptoms (LUTS) after artificial urinary sphincter (AUS) implantation based on individual longitudinal changes of patient-reported outcomes. Methods: This retrospective study included 66 male patients with severe urinary incontinence who were treated with primary AUS implantation between 2009 and 2019. International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) and International Prostate Symptom Score (IPSS) questionnaires were used to evaluate continence status and LUTS preoperatively, 1, 3, and 12 months after activation, and then annually. The annual changes in scores were calculated with a linear mixed model. Results: Of the 66 patients, 63 (95%) achieved complete or social continence (number of pads used ≤1/d) at 1 month after activation. Mean preoperative ICIQ-SF, IPSS, and IPSS-quality of life (QOL) score were 18.9, 14.9, and 5.4, respectively; the corresponding scores at 1 month after activation were 4.5, 9.0, and 1.7 (all P <.001), respectively. During the mean follow-up period of 36 months, the annual changes in the scores from 1 month after activation were 0.51 (P =.002), −0.30 (P =.184), and 0.19 (P <.001), respectively. As for individual IPSS items, while incomplete emptying, frequency, urgency, and weak stream improved significantly 1 month after activation, no significant changes from 1 month after activation were observed except for longitudinal deterioration of incomplete emptying score (0.08/y, P =.029). Conclusion: Continence status and QOL score markedly improved by AUS implantation immediately, but deteriorated over time. Improved LUTS were maintained without a worsening trend, however.
KW - artificial urinary sphincter
KW - lower urinary tract symptoms
KW - patient-reported outcome
UR - https://www.scopus.com/pages/publications/85083315699
U2 - 10.1111/luts.12311
DO - 10.1111/luts.12311
M3 - 記事
C2 - 32281740
AN - SCOPUS:85083315699
SN - 1757-5664
VL - 12
SP - 240
EP - 244
JO - LUTS: Lower Urinary Tract Symptoms
JF - LUTS: Lower Urinary Tract Symptoms
IS - 3
ER -